Table 1

Clinicopathological presentations
case 1 case 2 case 3 case 4
age 60 61 70 79
menopausal age 52 49 52 53
complaint atypical genital bleeding atypical genital bleeding abdominal distension no symptom
a E2 (pg/ml) 52.0 48.7 83.0 50.0
a FSH (mIU/ml) 4.8 8.4 6.9 23.4
preoperative diagnosis GCT or thecoma thecoma GCT or thecoma thecoma, fibroma or Brenner tumor
treatment TAH, BSO TAH, BSO TAH, BSO, OMT TAH, BSO, OMT, TCx6
FIGO stage IA IA IA IC
follow-up NED 48 months NED 38 months NED 7 months NED 39 months
side left left right left
size (cm) 9x9 10x9 16x7 10x8
gross solid/yellow solid/yellow solid/yellow solid and cystic/gray-white
cervicovaginal smear (MI) not available 0/10/90 5/30/65 5/20/75
endometrial smear not available active active not performed
SCST components 20% (SCT) 50% (SCT>GCT) 80% (GCT>SCT) 50% (SCT)
other components - EMAF - EMAF and MCA
endometriosis - + - -
functioning stroma +++ + +++ +

a pre-operative.

FSH: follicle stimulating hormone, TAH: total abdominal hysterectomy, BSO: bilateral salpingo-oophorectomy.

OMT: omentectomy, TC: paclitaxel+ carboplatin, NED: no evidence of desease.

SCST: sex-cord stromal tumor, SCT: Sertori cell tumor, GCT: granulosa cell tumor.

EMAF: endometrioid adenofibroma, MCA: mucinous cystadenofibroma.

Katoh et al.

Katoh et al. Diagnostic Pathology 2012 7:164   doi:10.1186/1746-1596-7-164

Open Data